Surgifield Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 23-10-2024
- Paid Up Capital ₹ 0.22 M
as on 23-10-2024
- Company Age 22 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.16 Cr
as on 23-10-2024
- Satisfied Charges ₹ 7.50 Cr
as on 23-10-2024
- Revenue -3.85%
(FY 2023)
- Profit 45.06%
(FY 2023)
- Ebitda 19.79%
(FY 2023)
- Net Worth 11.24%
(FY 2023)
- Total Assets -11.13%
(FY 2023)
About Surgifield
The Corporate was formerly known as Surgi Field Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 0.22 M.
The company currently has active open charges totaling ₹8.16 Cr. The company has closed loans amounting to ₹7.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Subrata Dey, Parshati Dey, Pritul Dey, and One other member serve as directors at the Company.
- CIN/LLPIN
U51909WB2002PTC095236
- Company No.
095236
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Sep 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Surgifield?
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Subrata Dey | Director | 30-Sep-2002 | Current |
Parshati Dey | Director | 14-Sep-2005 | Current |
Pritul Dey | Director | 01-Apr-2009 | Current |
Preyoti Dey | Director | 28-Jan-2019 | Current |
Financial Performance and Corporate Structure Insights of Surgifield.
Surgifield Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.85% decrease. The company also saw a substantial improvement in profitability, with a 45.06% increase in profit. The company's net worth Soared by an impressive increase of 11.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Surgifield?
In 2023, Surgifield had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 20 Dec 2019 | ₹8.16 Cr | Open |
Others Creation Date: 28 Aug 2018 | ₹6.00 Cr | Satisfied |
Others Creation Date: 31 Mar 2011 | ₹1.50 Cr | Satisfied |
How Many Employees Work at Surgifield?
Unlock and access historical data on people associated with Surgifield, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Surgifield, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Surgifield's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.